Details of the Drug

General Information of Drug (ID: DMPZ18B)

Drug Name

RI-001

Synonyms

RespImmune; RSV-IVIG; Respiratory syncytial virus infection therapy, ADMA Biologics

Indication

Disease Entry	ICD 11	Status	REF
Respiratory syncytial virus infection	1C80	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00632463) RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness. U.S. National Institutes of Health.